However, in 39 melanoma samples obtained from patients in the Melanoma Research Victoria cohort, incrementally increasing EZH2 protein expression was observed from early stage to metastatic disease (Fig. 3A), confirming published data [7]. The gene discussed is EZH2; the disease is metastatic neoplasm.